M

Metropolitan Hospital | 4th Oncology Department

Research site
(Unclaimed)
Location
9 Ethnarchou Makariou and 1 Venizelou Streets Neo Faliro, Piraeus, Attica, Greece

Site insights

Top conditions

Top treatments

Telisotuzumab
Pembrolizumab
Adagrasib
Lomitapide
Binimetinib
Docetaxel
LGX818
Encorafenib
Vemurafenib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the...

Active, not recruiting
Melanoma
Drug: Binimetinib
Drug: Encorafenib

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor,...

Enrolling
Non Small Cell Lung Cancer
Drug: Docetaxel
Biological: Telisotuzumab Vedotin

Study 849-017 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemothera...

Enrolling
Advanced NSCLC
Metastatic Lung Cancer
Drug: Adagrasib oral dose of 400 mg twice daily tablets
Combination Product: Pembrolizumab

This is 2-part, randomized, open label, multi-center, parallel group, phase III study comparing the efficacy and safety of LGX818 plus MEK162 to vemu...

Active, not recruiting
Melanoma
Drug: MEK162
Drug: vemurafenib

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for teliso...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Trial sponsors

AbbVie logo
Pfizer logo
A
Mirati Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems